Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Favorable phase I/II data presented for Xoma's Neuprex as pediatric meningococcemia treatment

Dec. 12, 1996

New antiviral agents from CNRS

Dec. 12, 1996

Milestone reached in Cubist/BMS antiinfective drug collaboration

Dec. 11, 1996

Positive results of fomivirsen in the treatment of CMV retinitis

Dec. 11, 1996

BMS reports results from cefprozil multicenter clinical study in AOM patients

Dec. 10, 1996

U.S. market introduction for novel antifungal formulation

Dec. 10, 1996

Japanese academic researchers isolate new quassinoid compound

Dec. 10, 1996

Pharmacia & Upjohn, McGill University claim antiparasitic MAb

Dec. 9, 1996

Cytovene approved for new indication in U.S.

Dec. 6, 1996

ChemGenics/Wyeth-Ayerst antibacterial drug discovery collaboration

Dec. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...